Tyra Biosciences (TYRA) Return on Capital Employed (2021 - 2026)

Quarterly Return on Capital Employed fell 1004.0% to 43.56% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 43.56% through Mar 2026, down 1004.0% year-over-year, with the annual reading at 43.53% for FY2025, 634.0% down from the prior year.

Tyra Biosciences filings provide 6 years of Return on Capital Employed readings, the most recent being 43.56% for Q1 2026.

  • Return on Capital Employed hit 43.56% in Q1 2026 for Tyra Biosciences, up from 48.43% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 12.39% in Q1 2022 and bottomed at 48.43% in Q4 2025.
  • Average Return on Capital Employed over 5 years is 29.35%, with a median of 28.68% recorded in 2024.
  • The largest annual shift saw Return on Capital Employed soared 773bps in 2024 before it crashed -1928bps in 2025.
  • Tyra Biosciences' Return on Capital Employed stood at 22.2% in 2022, then plummeted by -66bps to 36.88% in 2023, then grew by 21bps to 29.15% in 2024, then crashed by -66bps to 48.43% in 2025, then rose by 10bps to 43.56% in 2026.
  • Per Business Quant, the three most recent readings for TYRA's Return on Capital Employed are 43.56% (Q1 2026), 48.43% (Q4 2025), and 42.59% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 450.31%
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 51.73%
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -107.40%
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 21.10%
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 10.19%
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 20.34%
10 Tyra Biosciences 2.03 Bn 2.03 Bn - -43.56%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -43.56%
Dec 31, 2025 -48.43%
Sep 30, 2025 -42.59%
Jun 30, 2025 -38.17%
Mar 31, 2025 -33.52%
Dec 31, 2024 -29.15%
Sep 30, 2024 -26.75%
Jun 30, 2024 -24.59%
Mar 31, 2024 -28.68%
Dec 31, 2023 -36.88%
Sep 30, 2023 -29.62%
Jun 30, 2023 -23.88%
Mar 31, 2023 -22.74%
Dec 31, 2022 -22.20%
Sep 30, 2022 -19.50%
Jun 30, 2022 -16.28%
Mar 31, 2022 -12.39%
Dec 31, 2021 -8.54%